CHAPEL HILL, N.C., April 19, 2011 /PRNewswire/ -- The oncology market continues to be a rapid growth area for the biopharmaceutical industry, but managing all the aspects of successfully launching a new oncology product is challenging. In particular, global strategic marketing functions supporting the oncology therapeutic area are constantly assessing the appropriate budgets and resources needed to run a high-performing group.
Best Practices, LLC, a leader in biopharmaceutical benchmark and best practice research, has launched a comprehensive study to answer questions such as:
Pharma Leaders who oversee or work in Global Strategic Marketing for Oncology are invited to participate in the online survey and receive the full results at no cost. The study looks at Oncology Global Strategic Marketing activities in the United States, Europe, Asia or other headquarters locations and major markets.
This study will generate comparative metrics and executive insights that participants can use to evaluate and improve the effectiveness of their individual programs. All responses are blinded and aggregated to protect confidentiality. To participate, follow this link to the study: http://surveys.best-in-class.com/i/111848e9740690p153568
For assistance or questions related to this study, contact research team leader Martha Haswell at firstname.lastname@example.org or (919) 767-9249. Responses are requested by April 25, 2011.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 48 out of the top 50 pharmaceutical companies. For more information visit: http://www3.best-in-class.com.
|SOURCE Best Practices, LLC|
Copyright©2010 PR Newswire.
All rights reserved